NCT00289874View on ClinicalTrials.gov

Montelukast in Pediatric Allergic Asthma (0476-336)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

421

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Asthma
Interventions
DRUG

montelukast sodium

montelukast 5 mg chewable tablet once daily. Up to 3 weeks of treatment.

DRUG

Comparator: Placebo

Placebo. Up to 3 weeks of treatment

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00289874 - Montelukast in Pediatric Allergic Asthma (0476-336)(COMPLETED) | Biotech Hunter | Biotech Hunter